moelis & co. - MC
MC
Close Chg Chg %
73.40 0.89 1.21%
Open Market
74.28
+0.89 (1.21%)
Volume: 51.95K
Last Updated:
Nov 21, 2024, 10:35 AM EDT
Company Overview: moelis & co. - MC
MC Key Data
| Open $74.03 | Day Range 73.27 - 74.51 |
| 52 Week Range 44.06 - 81.53 | Market Cap $5.18B |
| Shares Outstanding 70.59M | Public Float 70.35M |
| Beta 1.34 | Rev. Per Employee N/A |
| P/E Ratio 138.01 | EPS $0.57 |
| Yield 327.07% | Dividend $0.60 |
| EX-DIVIDEND DATE Nov 4, 2024 | SHORT INTEREST N/A |
| AVERAGE VOLUME 717.39K |
MC Performance
| 1 Week | -1.75% | ||
| 1 Month | 2.89% | ||
| 3 Months | 8.23% | ||
| 1 Year | 63.18% | ||
| 5 Years | 121.16% |
MC Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
9
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | UNDERWEIGHT | Average Target Price | 65.429 | |
| Number of Ratings | 9 | Current Quarters Estimate | 0.393 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | 1.021 | |
| Last Quarter’s Earnings | 0.22 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | -0.20 | Next Fiscal Year Estimate | 2.349 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 9 | 9 | 9 | 9 |
| Mean Estimate | 0.39 | 0.45 | 1.02 | 2.35 |
| High Estimates | 0.52 | 0.64 | 1.15 | 2.80 |
| Low Estimate | 0.29 | 0.22 | 0.91 | 1.80 |
| Coefficient of Variance | 16.33 | 30.95 | 6.51 | 11.45 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 0 | 0 | 0 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 6 | 6 | 5 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 3 | 3 | 3 |
| MEAN | Underweight | Underweight | Underweight |
SEC Filings for Moelis & Co. - MC
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Moelis & Co. - MC
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Sep 27, 2024 | Louise Mirrer Director | 1,206 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 4, 2024 | John A. Allison Director | 1,061 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 4, 2024 | Laila J. Worrell Director | 1,938 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 4, 2024 | Kenneth L. Shropshire Director | 239 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 4, 2024 | Kenneth L. Shropshire Director | 2,030 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 4, 2024 | Laila J. Worrell Director | 1,061 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jul 4, 2024 | John A. Allison Director | 1,938 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 25, 2024 | Osamu R. Watanabe General Counsel, Secretary | 4,202 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 25, 2024 | Joe W. Simon Chief Financial Officer | 8,573 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 25, 2024 | Osamu R. Watanabe General Counsel, Secretary | 4,341 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 25, 2024 | Osamu R. Watanabe General Counsel, Secretary | 5,945 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 25, 2024 | Joe W. Simon Chief Financial Officer | 7,344 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 25, 2024 | John A. Allison Director | 335 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 25, 2024 | Kenneth L. Shropshire Director | 2,560 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 25, 2024 | Kenneth L. Shropshire Director | 76 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 25, 2024 | Navid Mahmoodzadegan Co-President, MD | 56,075 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 25, 2024 | Kenneth David Moelis Chairman, CEO; Director | 57,896 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 25, 2024 | John A. Allison Director | 2,444 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 25, 2024 | Jeffrey Raich Co-President, MD | 18,450 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 25, 2024 | Laila J. Worrell Director | 335 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |